- Home
- ALGS vs SGRP Comparison
ALGS vs SGRP Comparison
Compare ALGS & SGRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- SGRP
- Stock Information
- Founded
- ALGS 2018
- SGRP 1967
- Country
- ALGS United States
- SGRP United States
- Employees
- ALGS 70
- SGRP N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- SGRP Business Services
- Sector
- ALGS Health Care
- SGRP Consumer Discretionary
- Exchange
- ALGS Nasdaq
- SGRP Nasdaq
- Market Cap
- ALGS 27.9M
- SGRP 27.8M
- IPO Year
- ALGS 2020
- SGRP 1996
- Fundamental
- Price
- ALGS $5.36
- SGRP $1.14
- Analyst Decision
- ALGS Strong Buy
- SGRP
- Analyst Count
- ALGS 1
- SGRP 0
- Target Price
- ALGS $70.00
- SGRP N/A
- AVG Volume (30 Days)
- ALGS 184.5K
- SGRP 46.0K
- Earning Date
- ALGS 05-06-2025
- SGRP 05-14-2025
- Dividend Yield
- ALGS N/A
- SGRP N/A
- EPS Growth
- ALGS N/A
- SGRP N/A
- EPS
- ALGS N/A
- SGRP 0.50
- Revenue
- ALGS $3,945,000.00
- SGRP $228,869,000.00
- Revenue This Year
- ALGS $580.86
- SGRP N/A
- Revenue Next Year
- ALGS N/A
- SGRP N/A
- P/E Ratio
- ALGS N/A
- SGRP $2.24
- Revenue Growth
- ALGS N/A
- SGRP N/A
- 52 Week Low
- ALGS $3.76
- SGRP $1.04
- 52 Week High
- ALGS $46.80
- SGRP $3.12
- Technical
- Relative Strength Index (RSI)
- ALGS 33.94
- SGRP 37.04
- Support Level
- ALGS $4.33
- SGRP $1.04
- Resistance Level
- ALGS $5.67
- SGRP $1.16
- Average True Range (ATR)
- ALGS 0.78
- SGRP 0.07
- MACD
- ALGS 0.43
- SGRP 0.01
- Stochastic Oscillator
- ALGS 49.61
- SGRP 38.46
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.